ask="3.77"
ask_size="500"
average_daily_volume="43759"
bid="N/A"
bid_size="N/A"
book_value="-0.93"
change="-0.10"
change_from_200_day_moving_average="-0.32"
change_from_50_day_moving_average="-0.02"
change_from_52_week_high="-2.24"
change_From_52_week_low="1.45"
change_in_percent="-2.99%"
close="3.25"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.26"
ebitda="-50.77M"
eps_estimate_current_year="-2.06"
eps_estimate_next_quarter="-0.38"
eps_estimate_next_year="-1.48"
ex_dividend_date="N/A"
float_shares="10481000"
high="3.35"
high_52_weeks="5.49"
last_trade_date="3/17/2017"
last_trade_price="3.25"
last_trade_size="5361"
last_trade_time="4:00pm"
low="3.16"
low_52_weeks="1.80"
market_capitalization="76.80M"
moving_average_200_day="3.57"
moving_average_50_day="3.27"
name="Oncobiologics
Inc."
notes="N/A"
one_year_target_price="9.67"
open="3.33"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-8.94%"
percent_change_from_50_day_moving_average="-0.69%"
percent_change_from_52_week_high="-40.80%"
percent_change_from_52_week_low="+80.17%"
previous_close="3.35"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="34.60"
revenue="2.29M"
shares_outstanding="23631000"
short_ratio="1.30"
stock_exchange="NGM"
symbol="ONS"
volume="16494"
weeks_range_52="1.80 - 5.49"
